Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation.

[1]  J. Duarte,et al.  [Adipose tissue and adipokines]. , 2006, Acta medica portuguesa.

[2]  M. Guerre-Millo.  Adipose tissue and adipokines: for better or worse. , 2004, Diabetes & metabolism.

[3]  E. Yeh,et al.  Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.

[4]  NoriyukiOuchi,et al.  Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose Tissue , 2003 .

[5]  S. Haffner,et al.  Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus , 2002, Circulation.

[6]  S. Grundy.  Obesity, metabolic syndrome, and coronary atherosclerosis. , 2002, Circulation.

[7]  Ose,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .

[8]  S. Ding,et al.  Modulation of porcine adipocyte beta-adrenergic receptors by hormones and butyrate. , 2000, Journal of animal science.

[9]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[10]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[11]  M. Pfeffer,et al.  Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .

[12]  M. Pfeffer,et al.  Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. , 1999, Circulation.

[13]  B. Hazenberg,et al.  The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. , 1988, Biochemical and biophysical research communications.